TY - JOUR T1 - Impact of ‘never use’ abbreviations (Error Prone Abbreviations-EPA’s) list on incidence of EPAs in inpatient medical prescriptions in apex tertiary care public hospital in India JF - medRxiv DO - 10.1101/2020.10.05.20206896 SP - 2020.10.05.20206896 AU - Arif Thachaparambil AU - Mohammad Kausar AU - R Mahesh AU - DK Sharma Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/14/2020.10.05.20206896.abstract N2 - Background Abbreviations are commonly used in medical records to save time and space but use in prescriptions can be a reason for communication failures and preventable harm during healthcare delivery. Nearly 5% of medication errors can be attributable to abbreviation use. Prescriptions need to be clear so that nurses and pharmacists can correctly interpret intentions of doctors. For patient safety, hospitals should implement a process for uniform use of approved abbreviations, such as through use of an approved list or never-use list of abbreviations and symbols.Local Problem In the hospital under study, there was no system of avoiding error prone abbreviations while prescribing to prevent medical errors. Hence, an interventional study was done to quantify and reduce incidence of error prone abbreviations.Methods The study design was pre-post interventional / quasi-experimental design to assess the impact of never use list and standardized abbreviations. The study was conducted after ethical approval from Institute Ethics Committee. Pre intervention data was collected by a retrospective closed in-patient medical record review. Post interventional incidence of error prone abbreviations was determined and the effectiveness of the same was assessed by using statistical analysis.Intervention An approved ‘Never use’ list and standardized abbreviations were developed and poster copies were affixed in inpatient wards, doctors were educated and poster pamphlets were also distributed.Results Incidence of error abbreviations in inpatient prescription were 47.5% and ‘Never Use’ list of abbreviation led to a statistically significant reduction of error-prone abbreviation by 8.2% from 47.5% to 43.6% (P\0.006)Conclusion ‘Never Use’ lists are effective in reducing incidence of common error-prone abbreviations and discipline wise variation is observed. Adoption of such lists is highly recommended. The lists should be comprehensive, regularly updated and educational interventions should be comprehensive and integration into patient medical charts and pocket friendly flash cards may be provided for better outcomes. Enforcing a policy to prohibit the use of EPAs while prescribing will also be helpful.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding has been received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Ethics Committee IECPG-196All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data is available ER -